icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
 
 
 
Current Statin Use Reduces Risk of Viral Rebound on Suppressive cART
 
 
  Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
 
Henning Drechsler1,2Colby Ayers2James Cutrell1,2Naim Maalouf1,2Pablo Tebas3RogerBedimo1,2 1VA NorthTexas Health Care System, Dallas, TX, 2University of Texas Southwestern, Dallas, TX, 3University of Pennsylvania, Philadelphia, PA
 
from Jules: perhaps the mechanism is anti-inflammatory and anti immune activation effect of a statin or as the authors suggest some actual anti-viral affect.

0301171

0301172

0301173

0301174

0301175

0301176